Therefore, other anti-AD strategies targeting cholinergic neurons include BuChE inhibition and promotion of ChAT expression, as well as protection of cholinergic neurons by stimulating the expression of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and their receptors [6]. This evidence concerns the gene NGF and Alzheimer disease.